CRISPRa secondary pool screened with Vemurafenib using dCas9-VP64 in A375, Replicate A
A375 cells expressing dCas9-VP64 were infected with the CRISPRa secondary pool, Vemurafenib was added on Day 7, Day21 time point was collected, genomic DNA was PCR amplified and sequenced